Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.850
-0.010 (-0.54%)
At close: Apr 28, 2026, 4:00 PM EDT
1.850
0.00 (0.00%)
Pre-market: Apr 29, 2026, 7:32 AM EDT
Milestone Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -63.06 | -41.52 | -59.69 | -58.39 | -42.85 | |
| Depreciation & Amortization | 0.7 | 0.65 | 0.6 | 0.48 | 0.36 | |
| Other Amortization | 0.43 | 0.37 | 0.24 | - | - | |
| Loss (Gain) From Sale of Assets | - | 0.01 | - | 0.14 | - | |
| Loss (Gain) From Sale of Investments | -0.08 | -0.45 | -0.16 | -0.1 | - | |
| Stock-Based Compensation | 7.46 | 5.78 | 9.53 | 9.05 | 7.28 | |
| Other Operating Activities | 2.83 | 2.67 | 1.8 | -0.39 | -0.27 | |
| Change in Accounts Receivable | -0.16 | 1.72 | -2.33 | -0.76 | 0.1 | |
| Change in Inventory | -0.65 | - | - | - | - | |
| Change in Accounts Payable | 4.43 | 0.88 | 1.04 | -0.91 | 0.64 | |
| Change in Other Net Operating Assets | -0.94 | 1.06 | 2.53 | -1.6 | 1.52 | |
| Operating Cash Flow | -49.04 | -28.85 | -46.42 | -52.47 | -33.22 | |
| Capital Expenditures | -0.3 | -0.03 | -0.11 | -0.27 | - | |
| Investment in Securities | 11.55 | 8.32 | 4.87 | -56.85 | 70 | |
| Investing Cash Flow | 11.25 | 8.28 | 4.76 | -57.12 | 70 | |
| Long-Term Debt Issued | - | - | 50 | - | - | |
| Net Debt Issued (Repaid) | - | - | 50 | - | - | |
| Issuance of Common Stock | 82.95 | 27.5 | 0.58 | 3.09 | 0.12 | |
| Other Financing Activities | 2.57 | 4.62 | -2.79 | - | 4.93 | |
| Financing Cash Flow | 85.53 | 32.12 | 47.79 | 3.09 | 5.06 | |
| Net Cash Flow | 47.73 | 11.55 | 6.12 | -106.51 | 41.83 | |
| Free Cash Flow | -49.34 | -28.88 | -46.54 | -52.74 | -33.22 | |
| Free Cash Flow Margin | -3191.66% | - | -4653.60% | -1054.82% | -221.49% | |
| Free Cash Flow Per Share | -0.59 | -0.46 | -1.08 | -1.24 | -0.79 | |
| Levered Free Cash Flow | -28.9 | -18.12 | -28.29 | -31.36 | -17.05 | |
| Unlevered Free Cash Flow | -26.94 | -16.25 | -26.94 | -31.36 | -17.05 | |
| Change in Working Capital | 2.68 | 3.66 | 1.24 | -3.26 | 2.26 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.